Fucoidans in Nanomedicine

被引:91
作者
Chollet, Lucas [1 ,2 ,3 ]
Saboural, Pierre [1 ,2 ]
Chauvierre, Cedric [1 ,2 ]
Villemin, Jean-Noel [3 ]
Letourneur, Didier [1 ,2 ]
Chaubet, Frederic [1 ,2 ]
机构
[1] Univ Paris Diderot, Bichat Hosp 10, INSERM, LVTS,U1148, F-75877 Paris, France
[2] Univ Paris 13, Sorbonne Paris Cite, Galilee Inst, F-93430 Villetaneuse, France
[3] Algues & Mer, F-29242 Kernigou, Ouessant, France
关键词
fucoidans; nanomedicine; sulfated polysaccharides; nanosystems; drug delivery; imaging agent; tissue regeneration; MOLECULAR-WEIGHT FUCOIDAN; FUNCTIONALIZED POLYSACCHARIDE MICROPARTICLES; INDUCED TUBE FORMATION; HERPES-SIMPLEX-VIRUS; COMBINED PHASE-I; SULFATED POLYSACCHARIDES; MARINE POLYSACCHARIDES; EXTRACELLULAR-MATRIX; ASCOPHYLLUM-NODOSUM; GAMMA-IRRADIATION;
D O I
10.3390/md14080145
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fucoidans are widespread cost-effective sulfated marine polysaccharides which have raised interest in the scientific community over last decades for their wide spectrum of bioactivities. Unsurprisingly, nanomedicine has grasped these compounds to develop innovative therapeutic and diagnostic nanosystems. The applications of fucoidans in nanomedicine as imaging agents, drug carriers or for their intrinsic properties are reviewed here after a short presentation of the main structural data and biological properties of fucoidans. The origin and the physicochemical specifications of fucoidans are summarized in order to discuss the strategy of fucoidan-containing nanosystems in Human health. Currently, there is a need for reproducible, well characterized fucoidan fractions to ensure significant progress.
引用
收藏
页数:24
相关论文
共 203 条
[51]   Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit [J].
Granert, C ;
Raud, J ;
Waage, A ;
Lindquist, L .
INFECTION AND IMMUNITY, 1999, 67 (05) :2071-2074
[52]   Heparin and low-molecular-weight heparin [J].
Gray, Elaine ;
Mulloy, Barbara ;
Barrowcliffel, Trevor W. .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) :807-818
[53]   Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis [J].
Haddad, Oualid ;
Guyot, Erwan ;
Marinval, Nicolas ;
Chevalier, Fabien ;
Maillard, Loic ;
Gadi, Latifa ;
Laguillier-Morizot, Christelle ;
Oudar, Olivier ;
Sutton, Angela ;
Charnaux, Nathalie ;
Hlawaty, Hanna .
MARINE DRUGS, 2015, 13 (11) :6588-6608
[54]   Nanotherapeutics in the EU: an overview on current state and future directions [J].
Hafner, Anita ;
Lovric, Jasmina ;
Lakos, Gorana Perina ;
Pepic, Ivan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :1005-1023
[55]   Antitumor Effects of Fucoidan on Human Colon Cancer Cells via Activation of Akt Signaling [J].
Han, Yong-seok ;
Lee, Jun Hee ;
Lee, Sang Hun .
BIOMOLECULES & THERAPEUTICS, 2015, 23 (03) :225-232
[56]  
HARROP H A, 1992, Biochemical Society Transactions, V20, p163S
[57]   Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease [J].
Heeba, Gehan H. ;
Morsy, Mohamed A. .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2015, 40 (03) :907-914
[58]   Industrial optimization of fucoidan extraction from Sargassum sp and its potential antioxidant and emulsifying activities [J].
Hifney, Awatief F. ;
Fawzy, Mustafa A. ;
Abdel-Gawad, Khayria M. ;
Gomaa, Mohamed .
FOOD HYDROCOLLOIDS, 2016, 54 :77-88
[59]   Tuning polyelectrolyte multilayer structure by exploiting natural variation in fucoidan chemistry [J].
Ho, Tracey T. M. ;
Bremmell, Kristen E. ;
Krasowska, Marta ;
Stringer, Damien N. ;
Thierry, Benjamin ;
Beattie, David A. .
SOFT MATTER, 2015, 11 (11) :2110-2124
[60]   Bioactive compounds in seaweed: functional food applications and legislation [J].
Holdt, Susan Lovstad ;
Kraan, Stefan .
JOURNAL OF APPLIED PHYCOLOGY, 2011, 23 (03) :543-597